IP Library Granted Patent US 9,795,738
Granted Patent B2
US 9,795,738 · App. 14/708,283 · Granted Oct 24, 2017

Intelligent therapy recommendation algorithim and method of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,738
App. No.
14/708,283
Granted
Oct 24, 2017
Kind
B2
Abstract

An algorithm and method of making intelligent therapy recommendations for insulin pump parameters is described. The pump parameters include basal rates, carbohydrate-to-insulin ratios (CIR), and insulin sensitivity factors (ISF). A determination of whether a therapy recommendation should be made is based on comparing an updated recommended change with a threshold. The updated recommended change to the pump parameter is made based on a previous recommended change to the pump parameter and the difference between a current blood glucose value and a targeted blood glucose level. The algorithm and method confirms the therapy recommendation is within safety parameters before displaying the therapy recommendation.

Claims (14)

1. A method of automatically making a therapy recommendation for adjusting a basal rate stored on an insulin pump, the method comprising the steps of:

obtaining a blood glucose value at the end of a time interval;

determining if an intervening event occurred during the time interval , wherein the intervening event changes the blood glucose value unrelated to the stored basal rate and thereby interferes with recommending a change to the stored basal rate;

recommending no change to the stored basal rate based on the blood glucose value if the intervening event occurred during the time interval;

updating a recommended change to the stored basal rate based on a previous day recommended change to the stored basal rate during that interval and the difference between the blood glucose value and a target blood glucose level if no intervening event occurred during the time interval;

comparing an absolute value of the updated recommended change to a predefined threshold value of the stored basal rate;

making no therapy recommendation if the updated recommended change does not exceed the threshold or the therapy recommendation is not within safety parameters;

making the therapy recommendation if the updated recommended change exceeds the threshold and the therapy recommendation is within safety parameters; and

displaying the therapy recommendation to adjust the stored basal rate.

2. The method of claim 1 , wherein the basal rate is an overnight basal rate.

3. The method of claim 1 , wherein the step of recommending no change to the stored basal rate further comprises: skipping the blood glucose value if the intervening event includes a meal or a correction bolus during the time interval before the blood glucose value was obtained.

4. The method of claim 1 , wherein the step of confirming the therapy recommendation is within safety parameters comprises:

reviewing recent blood glucose history; and

using a moving standard deviation analysis on the recent blood glucose history to confirm the blood glucose value is relatively consistent with the blood glucose history.

Assignments (1)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →